Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

Abstract

Mutations in certain genes that regulate the cell cycle, such as p16 and p53, are frequently found in human cancers1. However, tumor-specific mutations are uncommon in genes encoding cyclin E and the CDK inhibitor p27Kip1, two cell-cycle regulators that are also thought to contribute to tumor progression2–8. It is now known that levels of both cyclin E and p27 can be controlled by posttranscriptional mechanisms, indicating that expression of these proteins can be altered by means other than simply mutation of their respective genes9,10. Thus, changes in p27 and cyclin E protein levels in tumors might be more common than previously anticipated and may be indicators of tumor behavior.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

Nadia Harbeck, Frédérique Penault-Llorca, … Fatima Cardoso

References

  1. Clurman, B. & Roberts, J. cellcycle and cancer. J. Natl. Cancer Inst. 87, 1499–1501 (1995).

    Article  CAS  PubMed  Google Scholar 

  2. Pietenpol, J. et al. Assignment of the human p27Kip1 gene to 12p13 and its analysis in leukemias. Cancer Res. 55, 1206–1210 (1995).

    CAS  PubMed  Google Scholar 

  3. Ponce-Castaneda, M. et al. p27Kip1: Chromosomal mapping to 12p12–l2p13 and absence of mutations in human tumors. Cancer Res. 55, 1211–1214 (1995).

    CAS  PubMed  Google Scholar 

  4. Konstantin, S. et al. p27/Kip1 mutation found in breast cancer. Cancer Res. 56, 2400–2404 (1996).

    Google Scholar 

  5. Leach, F. et al. Amplification of cyclin genes in colorectal carcinomas. Cancer Res. 53, 1986–1989 (1993).

    CAS  PubMed  Google Scholar 

  6. Keyomarsi, K. et al. Cyclin E, a potential prognostic marker for breast cancer. Cancer Res. 54, 380–385 (1994).

    CAS  PubMed  Google Scholar 

  7. Said, T. & Medina, D. Cell cyclins and cyclin-dependent kinase activities in mouse mammary tumor development. Carcinogenesls 16, 823–830 (1995).

    Article  CAS  Google Scholar 

  8. Fero, M.L. et al. A syndrome of multi-organ hyperplasia with features of gigantism, tumorigenesis and female sterility in p27Kip1–deficient mice. Cell 85, 733–744 (1996).

    Article  CAS  PubMed  Google Scholar 

  9. Clurman, B., Sheaff, R., Thress, K., Groudine, M. & Roberts, J. Turnover of cyclin E by the ubiquitin-proteosome pathway is regulated by CDK2 binding and cyclin phosphorylation. Genes Dev. 10, 1979–1990 (1996).

    Article  CAS  PubMed  Google Scholar 

  10. Pagano, M. et al. Role of the ubiquitin-proteosome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269, 682–685 (1995).

    Article  CAS  PubMed  Google Scholar 

  11. Dulic, V., Lees, E. & Reed, S. Association of human cyclin E with a periodic G1–S phase protein kinase. Science 257, 1958–1961 (1992).

    Article  CAS  PubMed  Google Scholar 

  12. Koff, A. et al. Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell 66, 1217–1228 (1991).

    Article  CAS  PubMed  Google Scholar 

  13. Nourse, J. et al. lnterleukin-2-mediated elimination of p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372, 570–573 (1994).

    Article  CAS  PubMed  Google Scholar 

  14. Coats, S., Flannagan, W., Nourse, J. & Roberts, J. Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science 272, 877–880 (1996).

    Article  CAS  PubMed  Google Scholar 

  15. McGuire, W. & Clark, G. Prognostic factors and treatment decisions in axillarynode negative breast cancer. N. Engl. J. Med. 326, 1756–1761 (1992).

    Article  CAS  PubMed  Google Scholar 

  16. Dutta, A., Chandra, R., Leiter, L. & Lester, S. Cyclins as markers of tumor proliferation: Immunocytochemical studies in breast cancer. Proc. Natl. Acad. Sci. USA 92, 5386–5390 (1995).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Ohtsubo, M., Theodoras, A., Schumacher, J., Roberts, J. & Pagano, M. Human cyclin E, a nuclear protein essential for the Gl-to-S phase transition. Mol. Cell. Biol. 15, 2612–2624 (1995).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Ohtsubo, M. & Roberts, J. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259, 1908–1912 (1993).

    Article  CAS  PubMed  Google Scholar 

  19. Gerdes, J., Becker, M. & Key, G. Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues J. Pathol. 168, 85–86 (1992).

    Article  CAS  PubMed  Google Scholar 

  20. Lin, D. & Ying, Z. Cox regression with incomplete covariate measurements. J. Am. Statist. Assoc. 88, 1341–1349 (1993).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Porter, P., Malone, K., Heagerty, P. et al. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nat Med 3, 222–225 (1997). https://doi.org/10.1038/nm0297-222

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0297-222

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing